Skip to content

DERMA-TO

Active
Private limited companyfounded 2020active for 6 yearsMechelsesteenweg 9, 1970 Wezembeek-Oppem, BelgiumKBO/BCE: BE 0753.407.314
Summary

DERMA-TO has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1,000 and a net result of €50,493. Equity has been shrinking by about 29% per year since 2021. If that trend continues, it turns negative around financial year 2026. Its solvency ranks better than 5% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 27-08-2020 Normal situation
Activity
Specialist medical practice NACE 86220and 1 other
Establishment unit
2.306.234.881 1933 Zaventem, since 27-08-2020
Financial year end
31 December
Peppol
Reachable since 23-12-2025

Board and ownership

Board
  • CIULICA Raluca-MarilenaDirector · since 27-08-2020

Financial position

92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€74,909
▲ 6.9%
Turnover
≈ €170,000
estimated
Profit
€50,493
▲ 25.0%
Equity
€1,000
=
Total assets
€88,276
▼ 65.9%
Filed on 03-07-2026, 28 days before the deadline
Score breakdownraises riskEquity €1,000 (1.1% of total assets)lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 0.38, cash €27,528, halvedSize: total assets €88,276Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 33% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Average
Solvency 26+1
equity 1.1% of total assets
Liquidity 39-11
short-term debt 97.4% · cash 31.2%
Profitability 100+12
return on assets 57.2%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1%lowest value 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026highest value 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 6% of them on solvency, 9% on liquidity, 80% on profitability and 37% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 0.38, cash €27,528, halved
NBB · annual accounts
raises risk · Equity €1,000 (1.1% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €88,276
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 20678 sector peers (2025).
NBB · sector comparison
Position among 20678 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-07-2026, 28 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
28 days early
2024
21 days late
2023
30 days late
2022
60 days late
2021
23 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 5 accounts on average 21 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 23 August (4 of the last 5 accounts filed within 37 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Less equity than 95% of companies in human healthsector median €124,628 · 20,680 companies €1,000 View
  • Positive: 5 profitable years in a rowprofit 2025: €50,493 5 years View

Recent changes

  1. · Gazette deed Incorporation
All 8 events

Comparable companies

These companies have the same main activity as DERMA-TO: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €77,700 and €101,000, founded between 2020 and 2021.

CompanyTotal assetsGross margin
DERMA-TO Wezembeek-Oppem€88,276€74,909
JUNGLE PEACE Burdinne€81,085€70,059
Société médicale Nadia Withofs Chaudfontaine€93,280€81,991
DOCTEUR OLIVIER BONHOMME, PNEUMOLOGIE Blégny€84,964€66,359
JUVENTAS Brussel€78,231€68,957
PB Services Schoten€77,718€76,717
Dr. Darcis Dermatology Brussel€100,949€80,010
Full comparison

Key facts about DERMA-TO

What is the company number of DERMA-TO?
The company number of DERMA-TO is 0753.407.314. The VAT number is the same number with BE in front: BE 0753.407.314.
Where is DERMA-TO based?
The registered office is at Mechelsesteenweg 9, 1970 Wezembeek-Oppem.Company details
What does DERMA-TO do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DERMA-TO?
The legal form of DERMA-TO is Private limited company (BV).
When was DERMA-TO founded?
DERMA-TO was founded on 27-08-2020.
Is DERMA-TO still active?
Yes, DERMA-TO is an active enterprise in the KBO register.
What is the turnover of DERMA-TO?
The turnover in financial year 2025 is ≈ €170,000. This figure is estimated from the gross margin of €74,909 and 32 comparable companies (NACE 862). It probably lies between €130,000 and €220,000.Financials
Is DERMA-TO profitable?
In financial year 2025, DERMA-TO made a profit of €50,493.
Where can I find the annual accounts of DERMA-TO?
DERMA-TO filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DERMA-TO due?
DERMA-TO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.